We know how important it is for patients and families to be able to see visitors. Please help us keep our patients and staff as safe as possible by checking the guidance below before you visiting.
We recognise the impact that a long stay in hospital can have on families and the importance of maintaining strong communication. Our ward staff are keeping in touch with patients’ next of kin directly and our Voluntary Services team can help pass on personal messages from family and friends.
After suspending visiting earlier in the year, we are now able to offer limited visiting to some wards at the discretion of the nurse in-charge.”
We recognise the impact that a long stay in hospital can have on families and the importance of maintaining strong communication. Our ward staff are keeping in touch with patients’ next of kin directly and our Patient Advice and Liaison Service (PALS) can help pass on personal messages from family and friends.
The Queen Alexandra Hospital is located just on the hill slopes of Portsdown Hill overlooking Portsmouth. It is conveniently situated for both the M27 and A3M.
Family members and carers play an important role in supporting patients during an episode of ill health. We are committed to the active involvement of family members, friends and carers during a hospital stay. Family members and carers play an important role in supporting patients during an episode of ill health.
More information on visiting hospital for an appointment.
If you've had experience of using our services and would like to make a comment then please contact the Patient Advice and Liaison Service (PALS). Your views are very important to us and we would like to hear where you think improvements are needed or where things have gone so well that you would like to share your thanks or gratitude with the staff involved. When things have not gone so well then you can be sure that we want to hear from you, so please get in touch with PALS.
Our Strategy – Working Together, Improving Together
Our strategy sets out our vision, values, strategic aims and most importantly, how we will deliver against these ambitions for our patients, communities, and people in the future.
It is not just a document, it is for and about everyone at PHU, building on what we have achieved with a renewed focus on continuous improvement and the need to continue to work together and improve together to achieve our goals.
A full copy of the strategy can be downloaded here.
For more information, please visit our strategy webpage.
There are lots of opportunities for you to get involved with the Trust, from volunteering to attending our public meetings, our Annual General Meeting or our hospital open day which is held every year.
We welcome and value your feedback and use the views you share with us in a number of ways to learn and make improvements as well as sharing best practice. Feedback can be provided in a number of ways.
Date: 03 September 2021
Portsmouth Hospitals University NHS Trust (PHU) has successfully treated their first patient with new Stereotactic Ablative Body Radiotherapy (SABR) radiation treatment for early-stage lung cancer.
SABR is a highly focused radiation treatment that gives an intense dose of radiation concentrated on to the cancerous region. SABR uses multiple smaller, thin beams of radiation and limits the dose to the surrounding organs.
Dr Yoodhvir Nagar and Dr Hannah Bainbridge, consultant clinical oncologists at Queen Alexandra Hospital (QA), helped to implement the treatment alongside colleagues from medical physics and radiography.
Dr Nagar said: “We’re extremely proud to become one of the national centres in the UK to provide this exciting new treatment. Our teams have worked tirelessly to provide this and always put patient care first.”
The new radiotherapy treatment minimises damage to surrounding organs and has been found to reduce side effects. SABR is delivered in fewer sessions compared to conventional radiotherapy treatment and is an alternative to surgery for patients who are not fit or do not want surgery for early-stage lung cancer.
The first patient to receive this treatment at QA said: “It was an absolute relief to receive SABR. Years ago, it was a completely unknown treatment so I feel very lucky to have had the opportunity to receive it.
“The conventional treatment would have been too invasive and aggressive due to my COPD. I would have had to travel up to Guilford every other day to receive SABR and it would have been a massive disruption to my life. Having the treatment at QA was far more convenient and reduced a lot of my stress.”
“The staff at QA have been absolutely amazing,” the patient added. “They are always respectful and keep me informed. The treatment means a lot to me and I know it will mean a lot to many other people.”
In the coming months, the oncology and medical physics teams at QA will expand the usage of SABR treatment to other secondary cancers.
Dr Nagar added: “The teams have worked extremely hard to make this possible and we will continue to ensure our patients receive the best care possible.”